{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2021-N-1326\" sorted by posted_date descending", "rows": [["FDA-2021-N-1326-2177", "FDA", "FDA-2021-N-1326", "MEMORANDUM FOR THE RECORD", "Other", "Memorandum", "2022-04-28T04:00:00Z", 2022, 4, "2022-04-28T04:00:00Z", null, "2022-04-28T20:49:58Z", null, 0, 0, "090000648503fe6b"], ["FDA-2021-N-1326-1568", "FDA", "FDA-2021-N-1326", "Part 15 Hearing Presentations", "Other", "Additional Information", "2022-04-11T04:00:00Z", 2022, 4, "2022-04-11T04:00:00Z", null, "2022-04-11T19:41:05Z", null, 0, 0, "090000648500ca54"], ["FDA-2021-N-1326-1567", "FDA", "FDA-2021-N-1326", "Part 15 Hearing - transcript", "Other", "Transcript(s)", "2022-04-11T04:00:00Z", 2022, 4, "2022-04-11T04:00:00Z", null, "2022-04-11T19:40:29Z", null, 0, 0, "090000648500ca52"], ["FDA-2021-N-1326-1566", "FDA", "FDA-2021-N-1326", "Part 15 Hearing - video", "Other", "Additional Information", "2022-04-11T04:00:00Z", 2022, 4, "2022-04-11T04:00:00Z", null, "2022-04-11T18:34:08Z", null, 0, 0, "090000648500bb39"], ["FDA-2021-N-1326-1539", "FDA", "FDA-2021-N-1326", "Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2022-03-31T04:00:00Z", 2022, 3, "2022-03-31T04:00:00Z", null, "2022-03-31T12:50:05Z", "2022-06762", 0, 0, "0900006484fefb12"], ["FDA-2021-N-1326-0381", "FDA", "FDA-2021-N-1326", "Request for Extension from Covington & Burling LLP", "Other", "Request for Extension", "2022-03-18T04:00:00Z", 2022, 3, "2022-06-15T04:00:00Z", null, "2022-06-15T15:35:55Z", null, 0, 0, "0900006484fce0c2"], ["FDA-2021-N-1326-0014", "FDA", "FDA-2021-N-1326", "Part 15 Public Hearing Agenda - Final", "Other", "Agenda", "2022-03-11T05:00:00Z", 2022, 3, "2022-03-11T05:00:00Z", null, "2022-03-11T18:33:35Z", null, 0, 0, "0900006484fc4095"], ["FDA-2021-N-1326-0012", "FDA", "FDA-2021-N-1326", "Part 15 Public Hearing: Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox", "Other", "Agenda", "2022-03-10T05:00:00Z", 2022, 3, "2022-03-10T05:00:00Z", null, "2022-03-10T12:19:51Z", null, 0, 0, "0900006484fc1ef7"], ["FDA-2021-N-1326-0009", "FDA", "FDA-2021-N-1326", "Part 15 Public Hearing: Scientific Data and Information Related to the Residue of\nCarcinogenic Concern for the New Animal Drug Carbadox", "Other", "Agenda", "2022-03-04T05:00:00Z", 2022, 3, "2022-03-04T05:00:00Z", null, "2022-03-04T19:05:43Z", null, 0, 0, "0900006484fba380"], ["FDA-2021-N-1326-0003", "FDA", "FDA-2021-N-1326", "Determination of Carbadox (As Quinoxaline-2-Carboxylic (QCA) Residues in Swine Liver and Muscle Tissues after Drug Withdrawal", "Other", "Additional Information", "2022-02-18T05:00:00Z", 2022, 2, "2022-02-18T05:00:00Z", null, "2022-02-18T13:07:07Z", null, 0, 0, "0900006484f82f68"], ["FDA-2021-N-1326-0004", "FDA", "FDA-2021-N-1326", "CVM Response to Phibro Animal Health Corporation\u2019s September 18, 2020 Comments on CVM\u2019s July 20, 2020 Proposed Order to Revoke the Regulatory Method for Carbadox", "Other", "Additional Information", "2022-02-18T05:00:00Z", 2022, 2, "2022-02-18T05:00:00Z", null, "2022-06-19T01:51:03Z", null, 0, 0, "0900006484f82f6a"], ["FDA-2021-N-1326-0001", "FDA", "FDA-2021-N-1326", "Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments", "Proposed Rule", "Public Hearing", "2022-01-13T05:00:00Z", 2022, 1, "2022-01-13T05:00:00Z", "2022-06-11T03:59:59Z", "2022-06-16T01:00:32Z", "2022-00475", 0, 0, "0900006484f1e918"]], "truncated": false, "filtered_table_rows_count": 12, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2021-N-1326"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-1326", "results": [{"value": "FDA", "label": "FDA", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-1326", "results": [{"value": "Other", "label": "Other", "count": 10, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2021-N-1326", "results": [{"value": 2022, "label": 2022, "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&posted_year=2022", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2021-N-1326&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 882.6614869758487, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}